Vascular Disease Management
INSIGHT INTO DIAGNOSIS AND TREATMENT OF VASCULAR DISEASE
MANAGEMENT
Wednesday, July 23, 2008

SEARCH ARTICLES



Home | About
Current Issue
Archives
Subscribe
Board Members
Search Article Archives
Editor's Update
Events & Symposia
Industry News | Enews
Discussion Forum
Classifieds
Letter to the Editor
Comments/Suggestions
Editorial/Production
Author Information
Submit a Manuscript
Review a Manuscript
Order Article Reprints
Advertising
Advertising Specs
Online/Web Production

Featured Article

Commentary: Use of a Disposable Radiation Protective Table for Reducing Operator Radiation
Original Contribution:
Commentary: Use of a Disposable Radiation Protective Table for Reducing Operator Radiation

- Daniel Clair, MD


The EPics 1 study reported by Dall’Olmo et al,1 in this issue of Vascular Disease Management reports on one surgical group’s evaluation of patients age 60 and older, both male and female, with a history of surgical, coronary revascularization invited to participate in an abdominal aortic aneurysm (AAA) screening program. The authors identified aneurysms in 9% of males screened and 5% of females screened with the majority of these in both groups having been previously unrecognized. This study is important in that it confirms the presence of increased risk for the presence of AAA in a defined population with clinically significant coronary disease, and notes the presence of this problem in males and females.

The recently implemented SAAAVE Act (Screening Abdominal Aortic Aneurysms Very Efficiently Act, a provision of S. 1932, the Deficit Reduction Act of 2005) allows a one time ultrasound screening benefit to check for AAA in Medicare beneficiaries who are “at risk”. The population defined as being at risk includes men who have at least a 100-pack year smoking history and men and women with a family history of AAA. While we applaud this Act for subsidizing screening of patients at risk for AAA, there are clearly other groups of patients who are at high risk that are not addressed with this coverage. Additionally, large, population-based trials that have implemented screening among the elderly without regard to “risk” have clearly shown benefit in reducing aneurysm related deaths among screening participants.2,3

In assessing patients with coronary artery disease (CAD), the authors of the current study have identified a high-risk group of patients who clearly would benefit from screening. This increased risk affects both males and females with a history of CAD who have undergone surgical revascularization. Understanding the propensity for atherosclerosis to have systemic effects upon those afflicted, it would appear likely that atherosclerotic disease in other vascular beds would put patients at increased risk for the development of abdominal aortic aneurysm as well. Screening studies such as these are to be applauded as they provide additional data to physicians and legislators alike regarding the need to expand coverage for AAA screening in the Medicare population.

We look forward to more information regarding these increased risk groups to provide evidence for expansion of this coverage.



1. Dall’Olmo C, IppolitoAL, McIlduff J, et al. EPics I Study: Evaluation of possible abdominal aortic aneurysms (In patients who have undergone previous CABG). Vascular Disease Management 2007;4:16–20.
2. Thompson S, Kim L, Scott A, Screening for abdominal aortic aneurysm. Screening reduces deaths related to aneurysm. BMJ 2005;330:601.
3. Takagi H, Tanabashi T, Kawai N, et al. Abdominal aortic aneurysm screening reduces mortality: Metanalyses of randomized, controlled trials. Eur J Vasc Endovasc Surg 2007;33:132–133.

Vascular Disease Management - ISSN: 1553-8036 - Volume 4 - Issue 1 - January 2007 - Pages: 21 - 217

VASCULAR TOPICS

Peripheral Angioplasty
Thoracic Stent Grafts
Renal Stenting
Vena Cava Filter
Hemodialysis Management
Computed Tomography
PFO Closure
SFA Stenting
Carotid Stenting
Vessel Closure
Angiography
Carotid Endarterectomy
Ultrasound

Critical Limb Ischemia
Superficial Femoral Artery
Embolization
Device Based Thrombectomy
Pharmacological Management
MRA
Mesenteric Artery Stenting
AAA Stent Grafts
Iliac Stenting
Thrombolysis Procedures Using Drug Therapy

SUPPLEMENTS

Superior Mesenteric Artery Revascularization and Retrograde Visualization
This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.

HMP Increased Cutaneous Sensibility in Patients with Diabetic Neuropathy Utilizing a Pharmacological Approach — Clinical Case Evidence

This clinical case update was supported through an unrestricted educational grant from Pamlab, LLC.

A New Biological Approachto Below-Knee Revascularization
A Review of the GORE PROPATEN Vascular Graft:
The Combination That Lasts

This special supplement was made possible through a grant from W. L. Gore

Combining Bilayered Living Cell Therapy with Minimally Invasive Vein Surgery:
Current Treatment Strategies for Venous Ulcers

This activity is supported by an educational grant from Organogenesis.

Pharmacotherapy in Peripheral Vascular Disease

Platelet Inhibition in Critical Limb Ischemia and Peripheral Vascular Interventions
DAVID E. ALLIE, MD

An Overview of Pharmacotherapy during Percutaneous Peripheral Interventions of Thrombotic Lesions
NICOLAS W. SHAMMAS, MD, MS, FACC


The Important Properties of Contrast Media: Focus on Viscosity

This special supplement was made possible through a grant from Guerbet LLC

RECENTLY ADDED

Anticoagulation Techniques for Peripheral Vascular Interventions

Archived Webcast





© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd., Suite 100, Malvern, PA 19355
Phone: 800.237.7285 610.560.0500 Fax: 610.560.0502
Privacy Policy